| 1 | IMCC | IM Cannabis Corp. FY · 2025-12-31 | Pharmaceuticals | $881,724.66 | 0.0 |
| 2 | SNYR | SYNERGY CHC CORP. TTM · 2026-03-31 | Pharmaceuticals | $1M | 0.0 |
| 3 | NAII | NATURAL ALTERNATIVES INTERNATIONAL INC FY · 2026-06-30 | Pharmaceuticals | $8M | 0.1 |
| 4 | AVD | AMERICAN VANGUARD CORPORATION TTM · 2026-06-30 | Other | $42M | 0.1 |
| 5 | TRIB | TRINITY BIOTECH PLC FY · 2024-12-31 | Biotechnology | $5M | 0.1 |
| 6 | MTEX | MANNATECH INC FY · 2025-12-31 | Pharmaceuticals | $15M | 0.1 |
| 7 | CRIS | CURIS, INC. FY · 2025-12-31 | Pharmaceuticals | $2M | 0.2 |
| 8 | BTMD | biote Corp. TTM · 2026-06-30 | Pharmaceuticals | $33M | 0.2 |
| 9 | VHI | VALHI, INC. TTM · 2026-06-30 | Other | $405M | 0.2 |
| 10 | BHC | Bausch Health Companies Inc. TTM · 2026-06-30 | Pharmaceuticals | $2.2B | 0.2 |
| 11 | GURE | GULF RESOURCES, INC. FY · 2025-12-31 | Pharmaceuticals | $6M | 0.2 |
| 12 | OLN | Olin Corporation TTM · 2026-06-30 | Pharmaceuticals | $1.7B | 0.3 |
| 13 | USNA | USANA HEALTH SCIENCES, INC. TTM · 2026-07-04 | Pharmaceuticals | $276M | 0.3 |
| 14 | ALTO | ALTO INGREDIENTS, INC. FY · 2025-12-31 | Other | $284M | 0.3 |
| 15 | QDEL | QUIDELORTHO CORP TTM · 2026-06-28 | Biotechnology | $909M | 0.3 |
| 16 | FMC | FMC CORPORATION TTM · 2026-06-30 | Pharmaceuticals | $1.3B | 0.4 |
| 17 | LFVN | LIFEVANTAGE CORP FY · 2026-06-30 | Pharmaceuticals | $75M | 0.4 |
| 18 | SNDL | | Pharmaceuticals | $288M | 0.4 |
| 19 | RMTI | ROCKWELL MEDICAL, INC. FY · 2025-12-31 | Pharmaceuticals | $31M | 0.4 |
| 20 | COTY | | Other | $2.6B | 0.4 |
| 21 | NATR | NATURE’S SUNSHINE PRODUCTS, INC. TTM · 2026-06-30 | Pharmaceuticals | $224M | 0.5 |
| 22 | KRO | KRONOS WORLDWIDE, INC. FY · 2025-12-31 | Other | $857M | 0.5 |
| 23 | MOS | MOSAIC CO TTM · 2026-06-30 | Other | $6.0B | 0.5 |
| 24 | BON | BON NATURAL LIFE LIMITED FY · 2025-09-30 | Pharmaceuticals | $9M | 0.5 |
| 25 | MYGN | MYRIAD GENETICS, INC. TTM · 2026-06-30 | Biotechnology | $402M | 0.5 |
| 26 | DOW | | Other | $20.3B | 0.5 |
| 27 | HRTX | HERON THERAPEUTICS, INC. /DE/ FY · 2025-12-31 | Pharmaceuticals | $79M | 0.5 |
| 28 | AMTX | AEMETIS, INC TTM · 2026-06-30 | Other | $115M | 0.5 |
| 29 | TLRY | Tilray Brands, Inc. FY · 2026-05-31 | Pharmaceuticals | $497M | 0.5 |
| 30 | SCL | STEPAN COMPANY FY · 2025-12-31 | Other | $1.4B | 0.6 |
| 31 | LYB | LYONDELLBASELL INDUSTRIES N.V. TTM · 2026-06-30 | Other | $19.2B | 0.6 |
| 32 | EPC | EDGEWELL PERSONAL CARE COMPANY TTM · 2026-06-30 | Other | $1.3B | 0.6 |
| 33 | FUL | FULLER H B CO TTM · 2026-08-29 | Other | $2.7B | 0.7 |
| 34 | EMN | EASTMAN CHEMICAL CO TTM · 2026-06-30 | Other | $7.1B | 0.8 |
| 35 | FTLF | FITLIFE BRANDS, INC. TTM · 2026-06-30 | Pharmaceuticals | $87M | 0.9 |
| 36 | SMG | Scotts Miracle-Gro Co TTM · 2026-06-27 | Other | $2.9B | 0.9 |
| 37 | MTX | MINERALS TECHNOLOGIES INC. TTM · 2026-07-05 | Other | $2.0B | 0.9 |
| 38 | SRPT | SAREPTA THERAPEUTICS, INC. FY · 2025-12-31 | Pharmaceuticals | $1.8B | 1.0 |
| 39 | PAHC | Phibro Animal Health Corporation FY · 2026-06-30 | Pharmaceuticals | $1.5B | 1.0 |
| 40 | GOVX | GEOVAX LABS, INC. FY · 2025-12-31 | Pharmaceuticals | $3M | 1.0 |
| 41 | CBT | Cabot Corporation TTM · 2026-06-30 | Other | $3.8B | 1.1 |
| 42 | LXU | LSB Industries, Inc. TTM · 2026-06-30 | Other | $706M | 1.1 |
| 43 | AVNT | AVIENT CORPORATION FY · 2025-12-31 | Other | $3.6B | 1.1 |
| 44 | CSBR | CHAMPIONS ONCOLOGY, INC. TTM · 2026-07-31 | Pharmaceuticals | $69M | 1.1 |
| 45 | AMRN | AMARIN CORP PLC\UK FY · 2025-12-31 | Pharmaceuticals | $244M | 1.1 |
| 46 | NEUP | Neuphoria Therapeutics Inc. FY · 2025-06-30 | Pharmaceuticals | $18M | 1.1 |
| 47 | TRAW | Traws Pharma, Inc. TTM · 2025-09-30 | Pharmaceuticals | $6M | 1.2 |
| 48 | LXFR | LUXFER HOLDINGS PLC TTM · 2026-03-29 | Other | $466M | 1.3 |
| 49 | SLSN | Solesence, Inc. TTM · 2026-06-30 | Other | $71M | 1.3 |
| 50 | IOSP | INNOSPEC INC. FY · 2025-12-31 | Pharmaceuticals | $2.4B | 1.3 |
| 51 | VTRS | VIATRIS INC. TTM · 2026-06-30 | Pharmaceuticals | $20.1B | 1.4 |
| 52 | PPG | PPG INDUSTRIES INC TTM · 2026-03-31 | Other | $23.1B | 1.4 |
| 53 | ACNT | Ascent Industries Co. TTM · 2026-06-30 | Pharmaceuticals | $122M | 1.5 |
| 54 | CLX | CLOROX CO /DE/ TTM · 2026-03-31 | Other | $10.2B | 1.5 |
| 55 | RPM | RPM International Inc. TTM · 2026-08-31 | Other | $12.4B | 1.5 |
| 56 | CGC | Canopy Growth Corporation FY · 2026-03-31 | Pharmaceuticals | $320M | 1.6 |
| 57 | MGNX | MACROGENICS, INC. FY · 2025-12-31 | Pharmaceuticals | $237M | 1.6 |
| 58 | NAGE | NIAGEN BIOSCIENCE, INC. TTM · 2026-06-30 | Pharmaceuticals | $208M | 1.6 |
| 59 | ANIP | ANI PHARMACEUTICALS, INC TTM · 2026-06-30 | Pharmaceuticals | $1.7B | 1.7 |
| 60 | TOMZ | TOMI ENVIRONMENTAL SOLUTIONS, INC. TTM · 2026-06-30 | Other | $12M | 1.8 |
| 61 | OPK | OPKO Health, Inc. TTM · 2026-06-30 | Pharmaceuticals | $1.0B | 1.8 |
| 62 | LFCR | LIFECORE BIOMEDICAL, INC. FY · 2025-05-25 | Pharmaceuticals | $244M | 1.9 |
| 63 | BMRA | BIOMERICA, INC. FY · 2026-05-31 | Biotechnology | $8M | 1.9 |
| 64 | SCYX | SCYNEXIS, Inc. FY · 2025-12-31 | Pharmaceuticals | $40M | 1.9 |
| 65 | ALB | ALBEMARLE CORPORATION TTM · 2026-06-30 | Other | $11.6B | 2.0 |
| 66 | CDXS | Codexis, Inc. TTM · 2026-06-30 | Other | $154M | 2.0 |
| 67 | NL | NLI HOLDINGS, INC. TTM · 2026-06-30 | Other | $330M | 2.0 |
| 68 | REX | REX AMERICAN RESOURCES CORPORATION TTM · 2026-07-31 | Other | $1.4B | 2.1 |
| 69 | FSI | FLEXIBLE SOLUTIONS INTERNATIONAL INC. TTM · 2026-06-30 | Other | $78M | 2.2 |
| 70 | KVUE | Kenvue Inc. TTM · 2026-06-28 | Other | $34.2B | 2.2 |
| 71 | CF | CF INDUSTRIES HOLDINGS, INC. TTM · 2026-06-30 | Other | $17.3B | 2.2 |
| 72 | BCRX | BIOCRYST PHARMACEUTICALS, INC. TTM · 2026-06-30 | Pharmaceuticals | $2.1B | 2.3 |
| 73 | CPIX | Cumberland Pharmaceuticals Inc. FY · 2025-12-31 | Pharmaceuticals | $105M | 2.4 |
| 74 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC TTM · 2026-06-30 | Other | $21.7B | 2.4 |
| 75 | BMY | BRISTOL-MYERS SQUIBB COMPANY TTM · 2026-06-30 | Pharmaceuticals | $117.6B | 2.4 |
| 76 | IPAR | INTERPARFUMS, INC. TTM · 2026-06-30 | Other | $3.6B | 2.4 |
| 77 | EL | Estee Lauder Companies Inc FY · 2026-06-30 | Other | $36.2B | 2.4 |
| 78 | SOLS | Solstice Advanced Materials Inc. FY · 2025-12-31 | Pharmaceuticals | $9.6B | 2.5 |
| 79 | PFE | PFIZER INC TTM · 2026-06-28 | Pharmaceuticals | $161.9B | 2.5 |
| 80 | MNKD | MannKind Corporation TTM · 2026-06-30 | Pharmaceuticals | $1.0B | 2.6 |
| 81 | PLX | PROTALIX BIOTHERAPEUTICS, INC. TTM · 2026-06-30 | Pharmaceuticals | $224M | 2.8 |
| 82 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED FY · 2025-12-31 | Pharmaceuticals | $48.0B | 2.8 |
| 83 | UG | UNITED-GUARDIAN, INC. TTM · 2026-06-30 | Other | $32M | 2.8 |
| 84 | ACAD | ACADIA PHARMACEUTICALS INC. TTM · 2026-06-30 | Pharmaceuticals | $3.3B | 2.9 |
| 85 | AGEN | AGENUS INC FY · 2025-12-31 | Pharmaceuticals | $336M | 2.9 |
| 86 | NEOG | Neogen Corporation FY · 2026-05-31 | Biotechnology | $2.6B | 3.0 |
| 87 | LAB | Standard BioTools Inc. FY · 2025-12-31 | Pharmaceuticals | $258M | 3.0 |
| 88 | JAZZ | Jazz Pharmaceuticals plc TTM · 2026-06-30 | Pharmaceuticals | $14.1B | 3.1 |
| 89 | BMRN | BIOMARIN PHARMACEUTICAL INC TTM · 2026-06-30 | Pharmaceuticals | $10.7B | 3.1 |
| 90 | ICCC | ImmuCell Corporation FY · 2025-12-31 | Biotechnology | $87M | 3.2 |
| 91 | FTK | FLOTEK INDUSTRIES INC/CN TTM · 2026-06-30 | Other | $929M | 3.2 |
| 92 | ROG | ROGERS CORP TTM · 2026-03-31 | Other | $2.6B | 3.2 |
| 93 | HXL | Hexcel Corporation TTM · 2026-06-30 | Other | $6.4B | 3.2 |
| 94 | SXT | Sensient Technologies Corp TTM · 2026-06-30 | Other | $5.5B | 3.2 |
| 95 | ZTS | Zoetis Inc. TTM · 2026-06-30 | Pharmaceuticals | $31.3B | 3.3 |
| 96 | RIGL | RIGEL PHARMACEUTICALS, INC. TTM · 2026-06-30 | Pharmaceuticals | $912M | 3.3 |
| 97 | CL | COLGATE-PALMOLIVE COMPANY TTM · 2026-06-30 | Other | $71.7B | 3.4 |
| 98 | BIIB | BIOGEN INC. TTM · 2026-03-31 | Pharmaceuticals | $33.9B | 3.4 |
| 99 | VNRX | VOLITIONRX LIMITED FY · 2025-12-31 | Biotechnology | $6M | 3.5 |
| 100 | INVA | INNOVIVA, INC. FY · 2025-12-31 | Pharmaceuticals | $1.5B | 3.8 |